MetaCap

Corgi Genomics & Precision Medicine ETF (GNMX)

BATS: GNMXCorgi FundsHealthETFUSD

37.52+1.41 (+3.90%)

At close: Oct 9, 1:37 PM ET · Delayed 15 min

GNMX chart

Full chart

Key facts

Holdings
10
Inception
May 5, 2026
Issuer
Corgi Funds
Index tracked
—
Category
Health
52-week range
23.88 – 39.65
Volume / Avg
526 / 1.97K
Beta
—
Previous close
36.11

GNMX ETF today

The Corgi Genomics & Precision Medicine ETF (GNMX) is an exchange-traded fund from Corgi Funds in the Health category. It charges an expense ratio of 0.35%, or $35.00 per year on a $10,000 investment, and manages $2.9 million in assets. Its largest holding is Thermo Fisher Scientific Inc (TMO) at 8.46% of assets, and the top 10 positions make up 47.2% of the portfolio out of 10 holdings.

GNMX launched on May 5, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

GNMX top 10 holdings

GNMX holdings by weight
#HoldingWeight
1TMOThermo Fisher Scientific Inc8.46%
2MRNAModerna Inc8.35%
3VRTXVertex Pharmaceuticals Inc5.74%
4ILMNIllumina Inc4.72%
5TXG10x Genomics Inc Ordinary Shares - Class A3.82%
6GHGuardant Health Inc3.63%
7RVMDRevolution Medicines Inc Ordinary Shares3.32%
8IOVAIovance Biotherapeutics Inc3.15%
9TWSTTwist Bioscience Corp3.13%
10GMABGenmab AS ADR2.83%

Top 10 holdings: 47.2% of assets.

GNMX performance

1 week

-0.56%

1 month

+9.06%

3 months

+21.02%

GNMX price return, excluding dividends.

ETFs similar to GNMX

GNMX ETF FAQ

What is the GNMX price today?

GNMX last traded at $37.52 as of Oct 9, 1:37 PM EDT, up 3.90% on the day.

What is GNMX's expense ratio?

GNMX has an expense ratio of 0.35%, which works out to about $35.00 per year for every $10,000 invested.

What are GNMX's top holdings?

GNMX's largest holdings are Thermo Fisher Scientific Inc (8.46%), Moderna Inc (8.35%), Vertex Pharmaceuticals Inc (5.74%), Illumina Inc (4.72%), 10x Genomics Inc Ordinary Shares - Class A (3.82%). The top 10 make up 47.2% of the fund.

How big is GNMX?

GNMX has about $2.9 million in assets under management spread across 10 holdings.

Explore